STRS Ohio’s Olema Pharmaceuticals OLMA Stock Holding History

STRS Ohio’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$157K	Hold	10,500	–	–	﹤0.01%	1592
2025 Q4	$263K	Buy	+10,500	New	+$187K	﹤0.01%	1397
2022 Q2	–	Sell	-4,000	Closed	-$17K	–	2213
2022 Q1	$17K	Hold	4,000	–	–	﹤0.01%	2060
2021 Q4	$37K	Buy	4,000 +1,900	+90%	+$39.4K	﹤0.01%	2045
2021 Q3	$57K	Hold	2,100	–	–	﹤0.01%	2052
2021 Q2	$58K	Sell	2,100 -800	-28%	-$22.8K	﹤0.01%	2086
2021 Q1	$96K	Buy	+2,900	New	+$124K	﹤0.01%	1952

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

STRS Ohio's OLMA Position: Q1 2026 in Review

STRS Ohio held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 10,500 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

STRS Ohio first reported a position in OLMA in Q1 2021 and has held it in 7 quarters since. The position peaked at $263K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

STRS Ohio held 10,500 shares of Olema Pharmaceuticals worth $157K as of Q1 2026.
STRS Ohio left its Olema Pharmaceuticals share count unchanged in Q1 2026.
Olema Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1592 holding.
STRS Ohio first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
STRS Ohio's Olema Pharmaceuticals position peaked at $263K in Q4 2025.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.